Publication
Breathing Again
Treating asthma and COPD patients brings various benefits, such as better quality of life for patients and their families, higher output as a result of fewer days lost to sickness, and lower healthcare costs thanks to the improvement in patients’ health. Merely treating asthma patients with inflammation inhibitors yields social benefits of 127 million euros a year. This is the finding of research carried out by SEO Economic Research for De Long Alliantie Nederland.
Researchers
Lucy Kok
Publication date
01-01-2013
Publication number
2013-46
Area of expertise
Healthcare
Commissioned by
Long Alliantie Nederland
Published by
SEO Economic Research
Publication type
Report
ISBN
978-90-6733-727-4
Do you have any questions?
Contact our expert or fill in the form below. We will respond to your questions as soon as possible.
SEO Amsterdam Economics
"*" indicates required fields